101
edits
Changes
Jump to navigation
Jump to search
Line 5:
Line 5: − + − + +
Uploading content
If you have questions, please contact Health Canada's Medical Devices Directorate at hc.mdd.postmarket-postcommercialisation.dim.sc@canada.ca.
If you have questions, please contact Health Canada's Medical Devices Directorate at hc.mdd.postmarket-postcommercialisation.dim.sc@canada.ca.
== '''Links to guidance documents''' ==
== '''Links to online resources''' ==
Four guidance documents are available to support the interpretation of the new or updated post-market provisions in the Medical Devices Regulations that were published in Canada Gazette Part II on December 23, 2020.
Four guidance documents are available to support the interpretation of the new or updated post-market provisions in the Medical Devices Regulations that were published in Canada Gazette Part II on December 23, 2020. The "List of regulatory agencies and foreign jurisdictions" sets out the regulatory agencies and foreign jurisdictions for the purposes of section 61.2 of the ''Regulations''.
* [[Media:Guidance document links Post-Market FINAL EN.pdf|Links to guidance documents]]
* [[Media:Guidance document links Post-Market FINAL EN.pdf|Links to guidance documents]]
* [https://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/medeffect-canada/foreign-risk-notification-medical-devices-guidance/list.html List of regulatory agencies and foreign jurisdictions]
== '''Presentation slide decks''' ==
== '''Presentation slide decks''' ==
